How It Works

A three-step workflow from diagnosis to assets to measurement—built to stay maintainable and honest about what metrics can prove.

The operating hypothesis behind BioticaBio is that startups improve visibility among partners and investors when they publish a digitally discoverable, objective, and data-grounded narrative that makes asynchronous evaluation easier—so interest can form before and between live conversations. The third-party sources below do not speak to biotech specifically; they describe general B2B buying and trust dynamics that are useful analogs for how technical companies are screened online.

Step 1 — Diagnose hidden value

  • Identify where technical evidence lives (and where it conflicts)
  • Identify missing company-to-concept linkage
  • Define high-value terms and entities for your next diligence window

Step 2 — Build public-facing scientific assets

  • Create pages and summaries with a single navigable spine
  • Clarify mechanism and indication without flattening uncertainty
  • Connect evidence to brand identity without overclaiming

Step 3 — Measure discoverability

  • Track indexed pages and query impressions (directional)
  • Review concept-to-page visibility changes over time
  • Use analytics engagement as a secondary sanity check

Visibility metrics are directional and operational. They help teams see indexing and query trends; they do not prove fundraising or deal outcomes.